Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Development of Small-molecule SERCA Stimulators
Author(s): Antonio Zaza , Marcella Rocchetti Added: 5 months ago

Heart Failure
PERFORMANCE II: Two-Year Outcomes
Author(s): William Gray Added: 7 months ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego… View more

Vascular Disease and Surgery
ESC 25: The CARUSO Trial
Author(s): Tiziana Claudia Aranzulla Added: 3 months ago
ESC Congress 2025 - Evolocumab on top of lipid lowering therapy(LLT) reduced adverse vascular events at 12 months.Dr Tiziana Claudia Aranzulla (Mauriziano Umberto Hospital, Turin, IT) joins us to discuss findings from CARUSO (NCT04730973). The trial aimed to assess the efficacy of evolocumab with traditional LLT compared to traditional LTT alone in the stabilisation and regression of carotid… View more

Intervention

Prevention & Chronic Conditions
Occlutech PFO Closure Device: A Long-Term Review
Author(s): Daniela Trabattoni Added: 2 years ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more

Intervention
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 1 year ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention
Author(s): Finn Gustafsson Added: 1 year ago
HFA 24 - Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3 study (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were treated with two… View more

Anticoagulation

Heart Failure
Job title: Professor for Cardiac Surgery, University of Dresden
ProfDrMichael Knaut is a Professor for Cardiac Surgery atUniversity of Dresden. He attended medical school atMartin Luther University of Halle-Wittenberg. Since 1996, Prof Dr Knaut has worked at the Department of Cardiovascular and Thoracic Surgery, Heart Centre, University of Dresden. His scientific interests include rhythm surgery / surgical treatment of atrial fibrillation, minimally… View more
Job title: Associate Professor of Surgery
Dr Miguel Montero-Baker is an associate professor in the Division of Vascular Surgery and Endovascular Therapy, Baylor St. Luke’s Medical Center, Texas. He specialises in Diabetic Foot Amputation Prevention and Limb Salvage. Dr Montero-Baker graduated with honors both from medical school and his residency in Vascular Surgery at the University of Costa Rica. After his residency training, he was… View more
duane pinto
Job title: Associate Professor of Medicine
Dr. Pinto is a Harvard trained interventional cardiologist. An Assistant Professor of Medicine at Harvard Medical School, he has been the Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center since 2003. He has advanced training in biostatistics and research design with a Masters in Public Health from the Harvard School of Public Health. He is a… View more
William T Abraham
Research Area(s) / Expertise:

Heart Failure

 Job title: Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve… View more